LB

Luisa Beltran

I've been a business reporter for a while. I've covered Wall Street, venture capital and now private equity. I'm always looking for a scoop or something to talk about. I'm the eternal optimist and am still waiting for the Chicago Cubs to win the World Series. Yes, I believe.

Arbor exits Fieldbrook Foods

Arbor Investments said April 16 that it sold Fieldbrook Foods to Wells Enterprises Inc. Financial terms weren’t announced. Fieldbrook, of Dunkirk, New York, makes ice cream and frozen novelty products including ice cream sandwiches, cups, cones and stick novelties.

3 min read · 16 April 2019

Goyal joins Carlyle Group

Carlyle Group said April 16 that Pooja Goyal is joining the firm as partner and head of its renewable and sustainable energy team. Goyal was most recently head of the alternative energy investing group at Goldman Sachs.

3 min read · 16 April 2019

Woollatt joins Hamilton Lane

Hamilton Lane said April 16 that Mike Woollatt has joined the firm as a principal on the co-investment and fund investments team. Hamilton Lane has also opened an office in Toronto, which Woollatt will lead. Woollatt was most recently a director of strategic partnerships at OMERS.

4 min read · 16 April 2019

Bradley denies she caused Kainos "compensable harm"

It was Andrew Rosen, Kainos Capital’s managing partner, and not Sarah Bradley, who pushed the consumer-focused private equity firm to begin fundraising efforts “as soon as possible,” according to court documents filed April 15 in Delaware chancery state court. Discussions for Kainos Fund III began in late June and early July 2018, well before Bradley discovered that Kainos executives had allegedly fraudulently deprived her of her 25 percent stake in Kainos Manager, the filing said. Bradley, in her answer to Kainos’ counterclaim, denied that she caused any “compensable harm” to Kaino with her lawsuit and that any “economic or reputational injury” to Kainos was caused by the defendant’s own conduct, the filing said. Bradley, who is still listed on the Kainos site as a partner, claimed in a Jan. 25 lawsuit that Kainos cofounders perpetrated a fraudulent scheme to steal her 25 percent stake in the firm’s investment manager, Kainos Capital.

1 min read · 16 April 2019

Symplr closes IntelliSoft Group buy

Symplr said April 16 that it completed its buy of IntelliSoft Group. Financial terms weren’t announced. IntelliSoft, of Nashua, New Hampshire, provides medical credentialing, provider enrollment, and contract management software in combination with CVO services. Symplr is backed by Clearlake Capital Group and SkyKnight Capital.

4 min read · 16 April 2019

EQT weighs selling minority stake to outside investor: Bloomberg

EQT Partners added banks Goldman Sachs and Morgan Stanley to its lineup of banks advising on a review that could lead to an IPO, Bloomberg said. EQT is also considering selling a minority stake in the firm to a strategic investor, the story said.

1 min read · 16 April 2019

Centerbridge weighs options for Reddy Ice: Bloomberg

Centerbridge Partners is considering options for Reddy Ice Holdings Inc, including a sale, Bloomberg is reporting. A process is expected in the second half, the story said.

1 min read · 16 April 2019

Clearlake seeks buyer for Perforce Software: Bloomberg

Clearlake Capital has put Perforce Software up for sale and the process could fetch about $2 billion, Bloomberg reported. Clearlake has hired an adviser for the transaction, the story said. Perforce produces about $165 million in EBITDA, Bloomberg said.

1 min read · 16 April 2019

PE HUB Wire Highlights, 4.15.19

Catalent to buy Paragon Bioservices Inc for $1.2 bln; LPs try to get used to rise of subscription lines of credit; Revelstoke’s Crossroads sale heads to first round

2 min read · 15 April 2019

Catalent to buy Paragon Bioservices for $1.2 bln

Catalent Inc said April 15 that it agreed to buy Paragon Bioservices Inc for $1.2 billion. The deal calls for Catalent to issue $650 million of convertible preferred stock to Leonard Green & Partners LP. Paragon Bioservices produces biopharmaceuticals and vaccines. Paragon investors include NewSpring Capital and Camden Partners.

10 min read · 15 April 2019

Showing 1,241 to 1,250 of 12,294 results
1…124126…1000